A drug for treating diabetic nephropathy ⅳ stage of kidney deficiency and collateral stasis type

A technology for diabetic nephropathy and drugs, which is applied in drug combinations, urinary system diseases, metabolic diseases, etc., can solve problems such as the need to improve the curative effect, and achieve the effect of improving kidney function and reducing urinary protein
CN111529645BActive Publication Date: 2022-03-15上海市嘉定区中医医院
2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
上海市嘉定区中医医院
Publication Date
2022-03-15

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

A drug for treating kidney deficiency and collateral stasis type diabetic nephropathy stage IV, which consists of: 25-35g raw astragalus, 25-35g raw oyster, 25-35g Smilax, 25-35g Gorgon, 13-18g Hedyotis, ghost arrow Feather 8‑15g, Danshen 8‑13g, habitat 8‑12g, yam 7‑12g, dogwood 8‑12g, mulberry octopus 5‑12g. The present invention removes Scrophulariaceae, Atractylodes atractylodes, Radix Puerariae, Safflower, Alisma, and Rosa laevigata on the basis of Ziyue Yishen formula, and adds raw oyster, Hedyotis, ghost arrow feather, salvia miltiorrhiza, and mulberry octopus to strengthen blood circulation. Dispersing stagnation, removing blood stasis and dredging collaterals, clearing heat and detoxifying, so as to improve kidney function and reduce urine protein.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a medicine for treating the fourth stage of diabetic nephropathy of kidney deficiency and collateral stasis type, in particular a medicine prepared by adding and subtracting prescriptions on the basis of empirical prescription Zibi Yishen prescription. Background technique

[0002] Diabetic nephropathy (DN) is a common and refractory microvascular complication of diabetes, and it is one of the main causes of death and disability in patients. Early detection of kidney damage, seeking active and effective treatment, and maximizing the control of DN (stage IV) disease are of great significance for delaying the progression of the disease and improving the quality of life of patients. Modern studies have shown that the occurrence and development of DN are closely related to protein non-enzymatic glycosylation, high blood viscosity, and hemodynamic abnormalities caused by high blood sugar. At present, the "Guidelines for the Prevent...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More